Pravastatin (Smith et al., 2016; Vincenzi et al., 2014) and varenicline (Smith et al., 2016) did not show beneficial effects on cognition. Infrequency of cognition as a primary outcome complicates the drawing of firm conclusions in current studies. In addition, the inclusion of patients ...